Jacob Coxon to testify at New York City Council hearing on AI risks

Meta: Meta develops large-scale AI models and infrastructure as part of its efforts in social platforms and emerging technologies. The company has committed representatives to appear at regulatory discussions on AI risks. Its participation in the New York City Council hearing reflects its role among the world's major AI developers responding to calls for oversight. Google: Google, part of Alphabet, develops advanced AI systems through its Google DeepMind unit and other initiatives focused on model training and applications. The company maintains a significant presence in AI development and research. Its representatives are scheduled to testify at the upcoming New York City Council hearing on AI dangers alongside other major firms. OpenAI: OpenAI is a leading AI research and deployment organization known for developing frontier models such as the GPT series. It has been central to the rapid advancement of generative AI capabilities. Executives from OpenAI are expected to participate in the New York City Council hearing to address concerns about AI safety and control raised by recent whistleblowers. Jacob Coxon: Jacob Coxon is a 27-year-old British AI researcher who worked on pretraining at OpenAI and later Anthropic before resigning in early September 2026. He publicly warned that leading AI labs are racing toward self-improving superintelligence without adequate safety measures, describing it as gambling with human lives and potentially leading to catastrophic outcomes. His recent testimony at the New York City Council hearing stems directly from these warnings, where he joins company representatives to discuss AI risks. Local Regulation Push: New York City Council is convening a rare Committee of the Whole hearing to examine AI risks and consider legislative safeguards following high-profile concerns from industry insiders. AI Whistleblower Impact: Recent resignations and public warnings from AI researchers have intensified scrutiny on frontier labs' safety practices ahead of regulatory hearings.